This site is intended for healthcare professionals
Ovary under the microscope, cell image, pink and purple
PARP inhibitor selection in ovarian cancer

Meet the experts

Last updated: 13th Jul 2021
Published: 13th Jul 2021

As you navigate this Learning Zone, you will hear expert opinions to help guide you on your learning journey.

Dr Mansoor Raza Mirza

Dr Mansoor Raza Mirza specialises in medical and radiation oncology. He is Chief Oncologist at Rigshospitalet, Copenhagen University Hospital in Denmark and Medical Director of the Nordic Society of Gynaecologic Oncology—Clinical Trial Unit. He is Chairman of the European Network of Gynaecological Oncological Trials Group (ENGOT), Chairman of European Society of Gynaecological Oncology (ESGO) Council Scientific Committee, Chairman of Gynecologic Cancer Inter Group (GCIG) Phase 1-2 Committee, and a member of several faculties including the European Society of Medical Oncology (ESMO) Scientific Committee, European School of Oncology (ESO) and American Society of Clinical Oncology (ASCO) Master-Class Program.

Professor Isabelle Ray-Coquard

Professor Isabelle Ray-Coquard is Professor of medical oncology in University Claude Bernard Lyon I in France, medical oncologist in the regional Comprehensive Cancer Center at Centre Leon Bérard, and Network Director of the national observatory dedicated to rare ovarian cancer. In addition, Professor Ray-Coquard is President of the GINECO (Groupe d'Investigateurs Nationaux pour les Etudes des Cancers de l'Ovaire) group, and an active member of a number of professional groups including the American Society of Clinical Oncology, the American Association for Cancer Research, the Connective Tissue Oncology Society, the French Society of Cancer, the European Association of Cancer Research, the EORTC (European Organisation for Research and Treatment of Cancer) organisation and the European Society of Medical Oncology and the European Society of Gynaecological Oncology.